RNASEK and cancer: By cross-referencing the results confirmed by two databases, TIMER and UALCAN, we concluded that RNASEK was commonly upregulated in six types of cancers, including BLCA, CHOL, ESCA, HNSC, LIHC, and THCA (Figures 1A-1G).